Viewing Study NCT02153905


Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2026-04-23 @ 7:18 PM
Study NCT ID: NCT02153905
Status: TERMINATED
Last Update Posted: 2019-06-17
First Post: 2014-05-31
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: 140110
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators